<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37488110</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2158-3188</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Translational psychiatry</Title><ISOAbbreviation>Transl Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Associations of cardiovascular risk factors and lifestyle behaviors with neurodegenerative disease: a Mendelian randomization study.</ArticleTitle><Pagination><StartPage>267</StartPage><MedlinePgn>267</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">267</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41398-023-02553-9</ELocationID><Abstract><AbstractText>Previous observational studies reported that midlife clustering of cardiovascular risk factors and lifestyle behaviors were associated with neurodegenerative disease; however, these findings might be biased by confounding and reverse causality. This study aimed to investigate the causal associations of cardiovascular risk factors and lifestyle behaviors with neurodegenerative disease, using the two-sample Mendelian randomization design. Genetic variants for the modifiable risk factors and neurodegenerative disease were extracted from large-scale genome-wide association studies. The inverse-variance weighted method was used as the main analysis method, and MR-Egger regression and leave-one-out analyses were performed to identify potential violations. Genetically predicted diastolic blood pressure (DBP: OR per 1&#x2009;mmHg, 0.990 [0.979-1.000]), body mass index (BMI: OR per 1&#x2009;SD, 0.880 [0.825-0.939]), and educational level (OR per 1&#x2009;SD, 0.698 [0.602-0.810]) were associated with lower risk of late-onset Alzheimer's disease (LOAD), while genetically predicted low-density lipoprotein (LDL: OR per 1&#x2009;SD, 1.302 [1.066-1.590]) might increase LOAD risk. Genetically predicted exposures (including LDL and BMI) applied to familial AD showed the same effect. The association of LDL was also found with Amyotrophic lateral sclerosis (ALS) (LDL: OR per 1&#x2009;SD, 1.180 [1.080-1.289]). This MR analysis showed that LDL, BMI, BP, and educational level were causally related to AD; a significant association between LDL and ALS risk, as well as the potential effect of sleep duration on PD risk, were also revealed. Targeting these modifiable factors was a promising strategy of neurodegenerative disease prevention.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Liang-Yu</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ou</LastName><ForeName>Ya-Nan</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yu-Xiang</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontier Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zuo-Teng</ForeName><Initials>ZT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China. dr.tanlan@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jin-Tai</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0002-2532-383X</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontier Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China. yu-jintai@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Psychiatry</MedlineTA><NlmUniqueID>101562664</NlmUniqueID><ISSNLinking>2158-3188</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082742" MajorTopicYN="N">Heart Disease Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37488110</ArticleId><ArticleId IdType="pmc">PMC10366095</ArticleId><ArticleId IdType="doi">10.1038/s41398-023-02553-9</ArticleId><ArticleId IdType="pii">10.1038/s41398-023-02553-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565&#x2013;81. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Storm CS, Kia DA, Almramhi M, Wood NW. Using Mendelian randomization to understand and develop treatments for neurodegenerative disease. Brain Commun. 2020;2:fcaa031. doi: 10.1093/braincomms/fcaa031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa031</ArticleId><ArticleId IdType="pmc">PMC7425289</ArticleId><ArticleId IdType="pubmed">32954289</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Huang Y, Kou Q, Lu L, Jiang H, Li X, et al. Study on the role of an erythrocyte membrane-coated nanotheranostic system in targeted immune regulation of Alzheimer&#x2019;s disease. Adv Sci. 2023;10:e2301361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10288270</ArticleId><ArticleId IdType="pubmed">37075744</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944. doi: 10.1016/j.arr.2019.100944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2019.100944</ArticleId><ArticleId IdType="pubmed">31430566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou YN, Tan CC, Shen XN, Xu W, Hou XH, Dong Q, et al. Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies. Hypertension. 2020;76:217&#x2013;25. doi: 10.1161/HYPERTENSIONAHA.120.14993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.14993</ArticleId><ArticleId IdType="pubmed">32450739</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, et al. Evidence-based prevention of Alzheimer&#x2019;s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91:1201&#x2013;9. doi: 10.1136/jnnp-2019-321913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321913</ArticleId><ArticleId IdType="pmc">PMC7569385</ArticleId><ArticleId IdType="pubmed">32690803</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, et al. Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:31&#x2013;42. doi: 10.1007/s10654-017-0225-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0225-3</ArticleId><ArticleId IdType="pubmed">28097521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutsey PL, Misialek JR, Mosley TH, Gottesman RF, Punjabi NM, Shahar E, et al. Sleep characteristics and risk of dementia and Alzheimer&#x2019;s disease: the atherosclerosis risk in communities study. Alzheimers Dement. 2018;14:157&#x2013;66. doi: 10.1016/j.jalz.2017.06.2269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.06.2269</ArticleId><ArticleId IdType="pmc">PMC5776061</ArticleId><ArticleId IdType="pubmed">28738188</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng B, Yang Q, Joshi RB, Liu Y, Akbar M, Song BJ, et al. Role of alcohol drinking in Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and amyotrophic lateral sclerosis. Int J Mol Sci. 2020;21:7. doi: 10.3390/ijms21072316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072316</ArticleId><ArticleId IdType="pmc">PMC7177420</ArticleId><ArticleId IdType="pubmed">32230811</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27:R195&#x2013;R208. doi: 10.1093/hmg/ddy163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy163</ArticleId><ArticleId IdType="pmc">PMC6061876</ArticleId><ArticleId IdType="pubmed">29771313</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Zuber V, Matthews PM, Elliott P, Tzoulaki J, Dehghan A. Sleep, major depressive disorder, and Alzheimer disease: a Mendelian randomization study. Neurology. 2020;95:e1963&#x2013;e70.. doi: 10.1212/WNL.0000000000010463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010463</ArticleId><ArticleId IdType="pmc">PMC7682841</ArticleId><ArticleId IdType="pubmed">32817390</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik R, Georgakis MK, Neitzel J, Rannikmae K, Ewers M, Seshadri S, et al. Midlife vascular risk factors and risk of incident dementia: longitudinal cohort and Mendelian randomization analyses in the UK Biobank. Alzheimers Dement. 2021;17:1422&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33749976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol. 2017;155:171&#x2013;93.. doi: 10.1016/j.pneurobio.2015.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2015.07.003</ArticleId><ArticleId IdType="pubmed">26209472</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Daniel RM, Butterworth AS, Thompson SG, Consortium EP-I. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol. 2015;44:484&#x2013;95. doi: 10.1093/ije/dyu176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu176</ArticleId><ArticleId IdType="pmc">PMC4469795</ArticleId><ArticleId IdType="pubmed">25150977</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow DI, Kuchenbaecker KB, Shah S, Sofat R, Holmes MV, White J, et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol. 2016;45:1600&#x2013;16. doi: 10.1093/ije/dyw088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw088</ArticleId><ArticleId IdType="pmc">PMC5100611</ArticleId><ArticleId IdType="pubmed">27342221</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi: 10.1136/bmj.k601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k601</ArticleId><ArticleId IdType="pmc">PMC6041728</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichler I, Del Greco MF, Gogele M, Lill CM, Bertram L, Do CB, et al. Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med. 2013;10:e1001462. doi: 10.1371/journal.pmed.1001462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001462</ArticleId><ArticleId IdType="pmc">PMC3672214</ArticleId><ArticleId IdType="pubmed">23750121</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Tan L, Wang HF, Tan MS, Tan L, Li JQ, et al. Education and risk of dementia: dose-response meta-analysis of prospective cohort studies. Mol Neurobiol. 2016;53:3113&#x2013;23. doi: 10.1007/s12035-015-9211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9211-5</ArticleId><ArticleId IdType="pubmed">25983035</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufouil C, Alperovitch A, Tzourio C. Influence of education on the relationship between white matter lesions and cognition. Neurology. 2003;60:831&#x2013;6. doi: 10.1212/01.WNL.0000049456.33231.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000049456.33231.96</ArticleId><ArticleId IdType="pubmed">12629242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gutierrez L, Garcia-Alberca JM, Mendoza S, Gris E, De la Guia MP, Marin-Carmona JM, et al. The genetic research in Alzheimer disease (GERALD) initiative finds rs9320913 as a neural eQTL of lincRNA AL589740.1. Int J Alzheimers Dis. 2021;2021:3064224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455222</ArticleId><ArticleId IdType="pubmed">34557314</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y, Arenaza-Urquijo EM, Bartres-Faz D, Belleville S, Cantilon M, Chetelat G, et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2020;16:1305&#x2013;11. doi: 10.1016/j.jalz.2018.07.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.07.219</ArticleId><ArticleId IdType="pmc">PMC6417987</ArticleId><ArticleId IdType="pubmed">30222945</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson EL, Howe LD, Wade KH, Ben-Shlomo Y, Hill WD, Deary IJ, et al. Education, intelligence and Alzheimer&#x2019;s disease: evidence from a multivariable two-sample Mendelian randomization study. Int J Epidemiol. 2020;49:1163&#x2013;72. doi: 10.1093/ije/dyz280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz280</ArticleId><ArticleId IdType="pmc">PMC7660137</ArticleId><ArticleId IdType="pubmed">32003800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S, Walter S, Kauwe JSK, Saykin AJ, Bennett DA, Larson EB, et al. Genetically predicted body mass index and Alzheimer&#x2019;s disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimers Dement. 2015;11:1439&#x2013;51. doi: 10.1016/j.jalz.2015.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.015</ArticleId><ArticleId IdType="pmc">PMC4676945</ArticleId><ArticleId IdType="pubmed">26079416</ArticleId></ArticleIdList></Reference><Reference><Citation>Calio ML, Mosini AC, Marinho DS, Salles GN, Massinhani FH, Ko GM, et al. Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer&#x2019;s disease. Neurobiol Dis. 2021;148:105219. doi: 10.1016/j.nbd.2020.105219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105219</ArticleId><ArticleId IdType="pubmed">33301880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009;302:2565&#x2013;72. doi: 10.1001/jama.2009.1836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1836</ArticleId><ArticleId IdType="pmc">PMC2838501</ArticleId><ArticleId IdType="pubmed">20009056</ArticleId></ArticleIdList></Reference><Reference><Citation>Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ, et al. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement. 2017;8:165&#x2013;78..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520956</ArticleId><ArticleId IdType="pubmed">28761927</ArticleId></ArticleIdList></Reference><Reference><Citation>Danat IM, Clifford A, Partridge M, Zhou W, Bakre AT, Chen A, et al. Impacts of overweight and obesity in older age on the risk of dementia: a systematic literature review and a meta-analysis. J Alzheimers Dis. 2019;70:S87&#x2013;S99. doi: 10.3233/JAD-180763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180763</ArticleId><ArticleId IdType="pmc">PMC6700617</ArticleId><ArticleId IdType="pubmed">30689574</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer&#x2019;s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26:33. doi: 10.1186/s12929-019-0524-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0524-y</ArticleId><ArticleId IdType="pmc">PMC6507104</ArticleId><ArticleId IdType="pubmed">31072403</ArticleId></ArticleIdList></Reference><Reference><Citation>Broce IJ, Tan CH, Fan CC, Jansen I, Savage JE, Witoelar A, et al. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer&#x2019;s disease. Acta Neuropathol. 2019;137:209&#x2013;26. doi: 10.1007/s00401-018-1928-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1928-6</ArticleId><ArticleId IdType="pmc">PMC6358498</ArticleId><ArticleId IdType="pubmed">30413934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Xi Y, Yu H, An Y, Wang Y, Tao L, et al. 27-hydroxycholesterol promotes Abeta accumulation via altering Abeta metabolism in mild cognitive impairment patients and APP/PS1 mice. Brain Pathol. 2019;29:558&#x2013;73. doi: 10.1111/bpa.12698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12698</ArticleId><ArticleId IdType="pmc">PMC8028629</ArticleId><ArticleId IdType="pubmed">30582229</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer&#x2019;s disease. Neurobiol Dis. 2017;107:41&#x2013;56. doi: 10.1016/j.nbd.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5600438</ArticleId><ArticleId IdType="pubmed">27425887</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui L, Soliman ML, Geiger NH, Miller NM, Afghah Z, Lakpa KL, et al. Acidifying endolysosomes prevented low-density lipoprotein-induced amyloidogenesis. J Alzheimers Dis. 2019;67:393&#x2013;410. doi: 10.3233/JAD-180941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180941</ArticleId><ArticleId IdType="pmc">PMC6425476</ArticleId><ArticleId IdType="pubmed">30594929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459&#x2013;72. doi: 10.1093/eurheartj/ehx144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx144</ArticleId><ArticleId IdType="pmc">PMC5837225</ArticleId><ArticleId IdType="pubmed">28444290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane CA, Barnes J, Nicholas JM, Sudre CH, Cash DM, Parker TD, et al. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol. 2019;18:942&#x2013;52.. doi: 10.1016/S1474-4422(19)30228-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30228-5</ArticleId><ArticleId IdType="pmc">PMC6744368</ArticleId><ArticleId IdType="pubmed">31444142</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo JB, Toledo E, Weiner MW, Jack CR, Jr., Jagust W, Lee VM, et al. Cardiovascular risk factors, cortisol, and amyloid-beta deposition in Alzheimer&#x2019;s Disease Neuroimaging Initiative. Alzheimers Dement. 2012;8:483&#x2013;9. doi: 10.1016/j.jalz.2011.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.08.008</ArticleId><ArticleId IdType="pmc">PMC3668456</ArticleId><ArticleId IdType="pubmed">23102118</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson TG, Harrison S, Hemani G, Davey Smith G. An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome. Elife. 2019;8:e43657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6400585</ArticleId><ArticleId IdType="pubmed">30835202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou YN, Yang YX, Shen XN, Ma YH, Chen SD, Dong Q, et al. Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer&#x2019;s disease: a Mendelian randomization study. Alzheimers Res Ther. 2021;13:41. doi: 10.1186/s13195-021-00782-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00782-y</ArticleId><ArticleId IdType="pmc">PMC7874453</ArticleId><ArticleId IdType="pubmed">33563324</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Hammar N, Malmstrom H, Ingre C, Jungner I, Ye W, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017;81:718&#x2013;28. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Ho WY, Chang JC, Ling SC. Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon? FEBS J. 2021;289:7688&#x2013;7709.</Citation><ArticleIdList><ArticleId IdType="pubmed">34469619</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Trolese MC, Tortarolo M, Vallarola A, Freschi M, Pasetto L, et al. New insights on the mechanisms of disease course variability in ALS from mutant SOD1 mouse models. Brain Pathol. 2016;26:237&#x2013;47. doi: 10.1111/bpa.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12351</ArticleId><ArticleId IdType="pmc">PMC8029191</ArticleId><ArticleId IdType="pubmed">26780365</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, Haller E, Frisina-Deyo A, Mirtyl S, et al. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;28. doi: 10.1016/j.brainres.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.05.056</ArticleId><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Blume J, Rothenfusser E, Schlaier J, Bogdahn U, Lange M. Educational attainment and motor burden in advanced Parkinson&#x2019;s disease&#x2014;The emerging role of education in motor reserve. J Neurol Sci. 2017;381:141&#x2013;3. doi: 10.1016/j.jns.2017.08.3241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.08.3241</ArticleId><ArticleId IdType="pubmed">28991666</ArticleId></ArticleIdList></Reference><Reference><Citation>Holth JK, Fritschi SK, Wang C, Pedersen NP, Cirrito JR, Mahan TE, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science. 2019;363:880&#x2013;4. doi: 10.1126/science.aav2546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2546</ArticleId><ArticleId IdType="pmc">PMC6410369</ArticleId><ArticleId IdType="pubmed">30679382</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail S, Yu L, Schneider JA, Bennett DA, Buchman AS, Lim ASP. Sleep fragmentation and Parkinson&#x2019;s disease pathology in older adults without Parkinson&#x2019;s disease. Mov Disord. 2017;32:1729&#x2013;37. doi: 10.1002/mds.27200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27200</ArticleId><ArticleId IdType="pmc">PMC5778902</ArticleId><ArticleId IdType="pubmed">29082554</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, Dai XJ, Wang J, Wang Y. Association between sleep duration and Parkinson&#x2019;s disease varied across related orphan receptor A rs2028122 genotypes. Front Neurosci. 2022;16:902895.. doi: 10.3389/fnins.2022.902895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.902895</ArticleId><ArticleId IdType="pmc">PMC9235404</ArticleId><ArticleId IdType="pubmed">35769699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kip E, Parr-Brownlie LC. Healthy lifestyles and wellbeing reduce neuroinflammation and prevent neurodegenerative and psychiatric disorders. Front Neurosci. 2023;17:1092537.. doi: 10.3389/fnins.2023.1092537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1092537</ArticleId><ArticleId IdType="pmc">PMC9975355</ArticleId><ArticleId IdType="pubmed">36875655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashok A, Andrabi SS, Mansoor S, Kuang Y, Kwon BK, Labhasetwar V. Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: role of nanoparticle-based drug delivery systems in clinical translation. Antioxidants. 2022;11:408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8869281</ArticleId><ArticleId IdType="pubmed">35204290</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardillo-Diaz R, Perez-Garcia P, Castro C, Nunez-Abades P, Carrascal L. Oxidative stress as a potential mechanism underlying membrane hyperexcitability in neurodegenerative diseases. Antioxidants. 2022;11:518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9405356</ArticleId><ArticleId IdType="pubmed">36009230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackley SF, Zimmerman SC, Brenowitz WD, Tchetgen Tchetgen EJ, Gold AL, Manly JJ, et al. Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis. BMJ. 2021;372:n156. doi: 10.1136/bmj.n156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n156</ArticleId><ArticleId IdType="pmc">PMC7905687</ArticleId><ArticleId IdType="pubmed">33632704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>